Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive DNA testing for glaucoma: reality in 2003.

David A Mackey1, Jamie E Craig

  • 1Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, 32 Gisborne Street, East Melbourne, Victoria 3002, Australia. D.Mackey@utas.edu.au

Ophthalmology Clinics of North America
|January 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide discovery reveals 30 loci for choroidal thickness and uncovers potential causal links with angle-closure glaucoma.

medRxiv : the preprint server for health sciences·2026
Same author

Prevalence of Strabismus and Decreased Stereopsis in Parents of Children with Strabismus.

Ophthalmology·2026
Same author

Multi-Ancestry, Multitrait Polygenic Risk Scores for Myopia: Improved Accuracy and Clinical Potential.

Twin research and human genetics : the official journal of the International Society for Twin Studies·2026
Same author

Low-concentration atropine for management of myopia progression: does iris colour matter?

Eye (London, England)·2026
Same author

A large-scale genome-wide association meta-analysis for nevus count provides direct insights into the genetics of melanoma.

Nature communications·2026
Same author

Prenatal and childhood exposure to smoking and retinal nerve fibre layer thickness: A meta-analysis of three independent birth cohorts.

Acta ophthalmologica·2026
Same journal

Contrast sensitivity and measuring cataract outcomes.

Ophthalmology clinics of North America·2006
Same journal

Capsular tension rings: update on endocapsular support devices.

Ophthalmology clinics of North America·2006
Same journal

Management of vitreous loss and dropped nucleus during cataract surgery.

Ophthalmology clinics of North America·2006
Same journal

Astigmatism control.

Ophthalmology clinics of North America·2006
Same journal

New technology IOL optics.

Ophthalmology clinics of North America·2006
Same journal

Phaco fluidics and phaco ultrasound power modulations.

Ophthalmology clinics of North America·2006
See all related articles

DNA testing can identify high-risk glaucoma patients, guiding personalized screening. Careful evaluation of genetic testing benefits versus costs is crucial for effective glaucoma management.

Area of Science:

  • Ophthalmology
  • Genetics
  • Medical Diagnostics

Background:

  • Glaucoma diagnosis relies on clinical assessments like intraocular pressure and visual field analysis.
  • Emerging genetic discoveries necessitate robust studies to interpret DNA test results accurately.
  • Predictive DNA testing requires validated sensitivity, specificity, and genotype-phenotype correlations.

Purpose of the Study:

  • To evaluate the utility of DNA testing in identifying individuals at high risk for glaucoma.
  • To explore how genetic testing can alter glaucoma management strategies.
  • To assess the clinical and economic viability of genetic screening for glaucoma.

Main Methods:

  • Review of current clinical diagnostic methods for glaucoma.
  • Analysis of requirements for interpreting genetic test results, including prevalence and penetrance data.

Related Experiment Videos

  • Consideration of cost-effectiveness, ethical implications, and patient acceptability of genetic screening.

    • Main Results:

    • Myocilin gene testing may be beneficial for 3-5% of glaucoma patients, comparable to hereditary colorectal cancer screening yields.
    • Genetic testing can personalize clinical screening frequency for individuals within glaucoma pedigrees.
    • Negative genetic results can significantly reduce follow-up frequency for at-risk individuals.

    Conclusions:

    • DNA testing offers a valuable tool for personalized glaucoma risk assessment and management.
    • Further research is needed to establish definitive genotype-phenotype correlations and population-based data.
    • Integrating genetic insights into glaucoma care requires careful consideration of ethical, economic, and clinical factors.